C3 and C4 Complement Test Explained: Normal Range, Low Levels & Lupus (SLE) Monitoring (India 2026) | C3 C4 कॉम्प्लीमेंट टेस्ट गाइड
C3 and C4 Complement Test Explained: Normal Range, Low Levels & Lupus (SLE) Monitoring (India 2026)
C3 C4 कॉम्प्लीमेंट टेस्ट: नॉर्मल रेंज, कम स्तर का मतलब और ल्यूपस मॉनिटरिंग — पूरी गाइड
After a positive ANA Profile / ENA Panel, your rheumatologist will almost certainly order C3 and C4 Complement levels. These two proteins are the most important blood markers for monitoring disease activity in Systemic Lupus Erythematosus (SLE) — the most common serious autoimmune disease in young Indian women. Understanding your C3 and C4 levels tells your doctor whether lupus is in remission or heading into a flare, and whether your kidneys are at risk.
This guide explains C3 and C4 in simple English and Hindi — what the complement system is, normal ranges for Indian adults, what low C3/C4 means, which conditions cause abnormal complement beyond lupus, and why these tests are ordered alongside Anti-dsDNA, KFT, and ESR. For reading lab reports generally, see our beginner's guide to blood test reports.
ANA पॉजिटिव आने के बाद रूमेटोलॉजिस्ट C3 और C4 कॉम्प्लीमेंट का स्तर मांगते हैं। ये दोनों प्रोटीन SLE (ल्यूपस) में रोग गतिविधि की निगरानी के लिए सबसे महत्वपूर्ण मार्कर हैं। यह गाइड C3 C4 को सरल अंग्रेजी और हिंदी में समझाती है। Table of Contents / विषय सूची
What Is the Complement System? / कॉम्प्लीमेंट सिस्टम क्या है?
The complement system is a network of over 30 proteins produced primarily by the liver — part of the innate immune system. These proteins circulate in the blood in an inactive form and are activated in a cascade when pathogens, damaged cells, or immune complexes are detected. The three main activation pathways are: the classical pathway (activated by antibody-antigen complexes — the pathway activated in SLE), the lectin pathway, and the alternative pathway.
कॉम्प्लीमेंट सिस्टम मुख्यतः लीवर द्वारा बनाए गए 30 से अधिक प्रोटीनों का नेटवर्क है। ये प्रोटीन रक्त में निष्क्रिय रूप में घूमते हैं और जब रोगाणु, क्षतिग्रस्त कोशिकाएं, या प्रतिरक्षा जटिल पाए जाते हैं तो एक श्रृंखला में सक्रिय होते हैं। SLE में Classical Pathway सक्रिय होता है।Normal Range in India / भारत में सामान्य सीमा
*Reference ranges vary slightly between labs and assay methods. Always check the reference range on your specific lab report. Pregnancy causes a physiological rise in complement levels. C4 has genetic null alleles common in the Indian population that cause constitutively low C4 even without active disease.
*लैब के बीच सामान्य सीमाएं थोड़ी भिन्न होती हैं। C4 null alleles भारतीयों में आम हैं — ये सक्रिय बीमारी के बिना भी C4 कम कर सकते हैं।| Test / टेस्ट | Normal Range | Low / कम — meaning | High / उच्च — meaning |
|---|---|---|---|
| C3 कॉम्प्लीमेंट C3 |
90–180 mg/dL | Active SLE flare, lupus nephritis, PSGN, cryoglobulinaemia, liver disease | Acute phase reactant — rises with infection or acute inflammation |
| C4 कॉम्प्लीमेंट C4 |
15–45 mg/dL | Active SLE (falls earlier than C3), hereditary C4A null allele, HAE, immune complex diseases | Less significant; acute phase response |
Low C3 & C4 — Causes & What It Means
Low complement levels have multiple causes beyond SLE. The treatment differs entirely depending on the underlying condition:
कम C3 C4 के SLE के अलावा कई कारण हैं। अंतर्निहित कारण के आधार पर उपचार पूरी तरह अलग होता है।Both C3 and C4 fall during flares from immune complex consumption. Correlates with lupus nephritis (kidney involvement) — the most dangerous complication. Serial C3/C4 monitoring predicts flares 4–8 weeks before clinical symptoms. Ordered alongside Anti-dsDNA, KFT, urine protein, and CBC.
Occurs 2–4 weeks after streptococcal throat or skin infection (common in Indian children — see ASO Titer guide). C3 falls more dramatically than C4. Usually self-limiting — C3 normalises within 6–8 weeks. Persistent low C3 beyond 8 weeks requires evaluation for MPGN or SLE.
Mixed cryoglobulinaemia (associated with Hepatitis C — common in India — causes very low C4); subacute bacterial endocarditis (SBE); membranoproliferative glomerulonephritis (MPGN); systemic vasculitis. Each drives complement consumption via the classical pathway — similar mechanism to SLE but different context.
C4A null allele (very common in Indians — affects 20–30% in some estimates) causes constitutively low C4 without active disease. Hereditary Angioedema (HAE) from C1 esterase inhibitor deficiency causes recurrent very low C4 with normal C3 between attacks. Any patient with recurrent unexplained swelling without hives must have C4 measured.
Severe liver disease (cirrhosis, acute liver failure) impairs complement protein synthesis — causing low C3 and C4 from reduced production rather than consumption. Distinguished from immune-complex disease by clinical context and accompanying LFT abnormalities.
Severe nephrotic syndrome causes urinary protein loss — including loss of complement proteins — lowering C3 and C4 from depletion. Distinguishable from SLE by urinalysis pattern: massive proteinuria without haematuria (nephrotic) vs proteinuria + haematuria + red cell casts (lupus nephritis).
C3/C4 in Lupus (SLE) Monitoring
In SLE management, C3 and C4 are not one-time tests — they are longitudinal monitoring tools checked at every clinic visit. Serial changes in C3/C4 are far more clinically meaningful than a single isolated value.
SLE प्रबंधन में C3 C4 एकमुश्त परीक्षण नहीं हैं — ये हर क्लिनिक विजिट (स्थिर रोग में हर 3–6 महीने, flare में अधिक बार) में जांचे जाने वाले निगरानी उपकरण हैं।A trend of progressively falling C3 and C4 — even if still within normal range — is a warning sign. C3/C4 can begin to fall 4–8 weeks before clinical flare symptoms appear. This early warning allows the rheumatologist to pre-emptively adjust hydroxychloroquine or steroids. The single most valuable use of serial C3/C4 monitoring in SLE patients.
Lupus nephritis (kidney involvement) affects 50–60% of SLE patients in India — the most dangerous complication and a leading cause of chronic kidney disease in young Indian women. During a nephritis flare, C3 and C4 show the most dramatic drops, alongside rising creatinine and new proteinuria. Any SLE patient with both falling C3/C4 and new proteinuria needs urgent rheumatology review.
When C3 and C4 rise towards normal on serial measurements, this is the most objective evidence that immunosuppressive treatment is working — autoantibody production is being suppressed and complement consumption is reducing. Rising C3/C4 + falling Anti-dsDNA + improving clinical symptoms is the composite sign of SLE entering remission — may allow cautious steroid tapering under specialist supervision.
Some SLE patients have persistently low C4 even in full remission (C3 normal, Anti-dsDNA low, clinically well) — due to hereditary C4A null allele. More common in South Asians. In this situation C4 alone cannot be used as an activity marker. Your rheumatologist may confirm null allele by genetic typing and use C3 and Anti-dsDNA as the primary monitoring tools instead.
Other Conditions Causing Abnormal Complement
Caused by C1 esterase inhibitor deficiency — recurrent episodes of severe swelling (face, lips, larynx — potentially fatal) without hives. Characteristic pattern: very low C4 persistently (even between attacks), normal C3 between attacks. C4 is the screening test for HAE. Any patient with recurrent unexplained angioedema without urticaria must have C4 measured urgently.
Chronic Hepatitis C (common in India) causes mixed cryoglobulinaemia in ~50% of patients. Immune complexes activate complement — very low or undetectable C4, variably low C3. This pattern in a patient with joint pain, purpura, and neuropathy should prompt Hepatitis C testing before assuming SLE.
In severe RA with extra-articular manifestations, immune complex deposition can lower C3/C4. More commonly C3 is elevated in RA (acute phase protein). Ordered alongside Anti-CCP and RA Factor in complex RA presentations with systemic features.
Unlike C4, C3 behaves as an acute phase reactant and can rise with active infection or inflammation. This means in a patient with both SLE and an intercurrent infection, C3 may appear falsely "normal" or even elevated — masking ongoing complement consumption by immune complexes. High CRP in an SLE patient (CRP is usually normal in lupus flares) suggests co-existing infection, not pure lupus activity.
C3/C4 as Part of the Autoimmune Panel
C3 and C4 are always interpreted as part of the full lupus monitoring panel — never in isolation:
C3 C4 को हमेशा पूर्ण ल्यूपस निगरानी पैनल के हिस्से के रूप में देखा जाता है — अकेले नहीं।| Test | Role in SLE monitoring | Changes in active SLE |
|---|---|---|
| C3 & C4 | Complement consumption — overall disease activity, nephritis risk | Falls ↓ in flare |
| Anti-dsDNA | Most specific SLE antibody — correlates directly with renal disease | Rises ↑ in flare |
| ANA / ENA Panel | Diagnostic confirmation — Anti-Sm most specific for SLE | Positive at diagnosis; varies |
| ESR | Non-specific inflammation — elevates in SLE and infection | Rises ↑ |
| CRP | Usually normal in pure SLE flare — high CRP in SLE suggests infection | Often normal in SLE flare |
| CBC | Detects cytopenias: anaemia, leucopenia, thrombocytopenia | Low Hb, WBC, platelets ↓ |
| KFT / Creatinine | Monitors kidney function — rises when lupus nephritis damages glomeruli | Creatinine ↑ in nephritis |
✅ Book C3 C4 Complement Test or ANA Panel — Home Collection Available
C3 and C4 are most meaningful when ordered alongside Anti-dsDNA and ANA. Both options below give your rheumatologist the complete picture:
Affiliate links: I may earn a small commission at no extra cost to you. Government hospital rheumatology departments also offer C3/C4 testing. Always have results interpreted by a qualified rheumatologist — never adjust SLE medications based on lab values alone.
C3 C4 को ANA और Anti-dsDNA के साथ मंगाने पर रूमेटोलॉजिस्ट को पूरी तस्वीर मिलती है। घर से सैंपल कलेक्शन उपलब्ध है। Omega-3 Fish Oil — Immune Modulation Support in Autoimmune Conditions
Omega-3 fatty acids (EPA and DHA) have immunomodulatory properties — multiple studies show omega-3 supplementation reduces systemic inflammation, lowers ESR and CRP, and may modestly reduce autoimmune flare frequency in SLE when used alongside standard treatment. EPA and DHA reduce pro-inflammatory cytokine production (IL-1, IL-6, TNF-alpha) and shift immune responses towards less inflammatory pathways. Some evidence suggests omega-3 may help protect kidney function in lupus nephritis. Always consult your rheumatologist before starting any supplement — omega-3 can interact with anticoagulants and some immunosuppressants at high doses.
hk vitals Fish Oil 1000 mg — Omega 3 with EPA & DHA (60 Capsules)
High-quality fish oil providing EPA and DHA at therapeutic levels shown in research to modulate inflammatory pathways. Used as adjunct nutritional support alongside rheumatology treatment in autoimmune conditions including SLE, RA, and other inflammatory diseases. Consult your rheumatologist before starting any supplement — especially if on anticoagulants, methotrexate, or mycophenolate.
View on Amazon IndiaDisclosure: Affiliate link. We may earn a small commission at no extra cost to you.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside C3 and C4 in the autoimmune workup:
ऑटोइम्यून वर्कअप में C3 C4 के साथ ये जांचें अक्सर करवाई जाती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
Normal C3 for Indian adults is 90–180 mg/dL. Normal C4 is 15–45 mg/dL. These ranges are used by most major Indian diagnostic laboratories. Values below the lower limit indicate complement consumption — suggesting active immune complex disease such as an SLE flare, lupus nephritis, or post-infectious glomerulonephritis. C4 hereditary null alleles (very common in South Asians including Indians) can cause persistently low C4 even in completely healthy individuals — always ask your rheumatologist about this before interpreting an isolated low C4 as disease activity.
उत्तर: C3 सामान्य: 90–180 mg/dL। C4 सामान्य: 15–45 mg/dL। निचली सीमा से कम = कॉम्प्लीमेंट उपभोग। C4 null alleles (भारतीयों में आम) स्वस्थ व्यक्तियों में भी C4 कम कर सकते हैं।Not necessarily. Low C3 and C4 together is a strong signal of immune complex-mediated complement consumption, but SLE is not the only cause. Other important causes include post-streptococcal glomerulonephritis (very common in Indian children), Hepatitis C-associated cryoglobulinaemia, subacute bacterial endocarditis, and MPGN. SLE diagnosis requires low C3/C4 PLUS positive ANA PLUS positive Anti-dsDNA PLUS appropriate clinical features (malar rash, joint pain, oral ulcers, photosensitivity, serositis) using SLICC or ACR/EULAR 2019 criteria. Low complement alone is insufficient for SLE diagnosis.
उत्तर: जरूरी नहीं। C3 C4 दोनों कम होने के SLE के अलावा कई कारण हैं। SLE निदान के लिए: कम C3/C4 + ANA+ + Anti-dsDNA+ + नैदानिक विशेषताएं = आवश्यक।Yes — several non-lupus conditions cause low complement in India. The most common are: hereditary C4A null allele (persistently low C4 with normal C3 in healthy South Asians — very common), post-streptococcal glomerulonephritis in children (C3 falls dramatically, resolves in 6–8 weeks), Hepatitis C-associated cryoglobulinaemia (C4 very low), severe liver disease (impaired complement synthesis from cirrhosis), and rare hereditary complement deficiencies. Your doctor will use additional tests (urine microscopy, Hepatitis C serology, ASO titre, liver function) to identify the specific cause.
उत्तर: हां। C4 null allele (भारतीयों में बहुत आम), PSGN, Hepatitis C cryoglobulinaemia, गंभीर लीवर रोग — ये सभी SLE के बिना C3/C4 कम कर सकते हैं।During active disease or flare — check C3, C4, Anti-dsDNA, CBC, KFT, and urine protein monthly or at every clinic visit until stability. During stable remission — every 3–6 months alongside a full lupus monitoring panel. Before any planned medication change (tapering steroids). During pregnancy — monthly monitoring throughout and 3 months postpartum (SLE commonly flares in second/third trimester and postpartum). Serial trend over time is more valuable than a single result — your rheumatologist compares current values to previous results to assess trajectory.
उत्तर: सक्रिय रोग में: मासिक। स्थिर छुटकारे में: हर 3–6 महीने। गर्भावस्था में: मासिक। समय के साथ प्रवृत्ति एकल मान से अधिक मूल्यवान है।C3 and C4 levels are not directly raised by any food, supplement, or lifestyle change. They improve only when the underlying autoimmune activity is controlled with proper prescribed medicines (hydroxychloroquine, corticosteroids, mycophenolate mofetil, azathioprine, or biologics like belimumab). As disease activity reduces with treatment, complement consumption decreases and levels rise naturally. Taking Vitamin D supports overall immune regulation and is beneficial in SLE (Vitamin D deficiency is common in Indian SLE patients and worsens outcomes), but it does not directly raise C3/C4. Omega-3 fish oil may reduce overall autoimmune inflammation as adjunctive support. Never delay or reduce prescribed immunosuppressants in an attempt to "naturally" raise complement levels — this can trigger severe flares.
उत्तर: C3 C4 कोई भी खाद्य या सप्लीमेंट सीधे नहीं बढ़ाता। ये केवल उचित दवाओं से ऑटोइम्यून गतिविधि नियंत्रित होने पर बढ़ते हैं। विटामिन D SLE परिणामों में सहायक है लेकिन C3/C4 सीधे नहीं बढ़ाता।No — fasting is not required for C3 or C4 complement testing. Complement protein levels are not affected by food intake, meals, or time of day. The test can be done at any time after eating normally. No medication needs to be stopped before the test, and timing relative to medication doses does not affect complement levels. If C3/C4 is being ordered alongside fasting blood sugar or lipid profile (for monitoring cardiovascular risk or diabetes in SLE patients on steroids), follow those fasting instructions — the C3/C4 can be collected from the same blood draw without any additional preparation.
उत्तर: नहीं — C3 C4 के लिए उपवास बिल्कुल आवश्यक नहीं। भोजन से कॉम्प्लीमेंट प्रोटीन स्तर प्रभावित नहीं होते। कोई भी दवा रोकने की जरूरत नहीं।- NIAMS/NIH — Lupus: Lupus Patient Information — NIAMS
- MedlinePlus: Complement Test — Patient Information
- ACR/EULAR 2019: Classification Criteria for SLE — includes low complement (C3 < normal or C4 < normal) as a serological domain criterion (3 points each).
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. C3 and C4 results must always be interpreted by a qualified rheumatologist alongside clinical symptoms, ANA, Anti-dsDNA, kidney function, urine protein, and CBC. Never change your SLE medication (hydroxychloroquine, steroids, mycophenolate, azathioprine) based on lab reports alone. Abrupt steroid dose reduction can precipitate a severe lupus flare.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। C3 C4 हमेशा योग्य रूमेटोलॉजिस्ट द्वारा पूर्ण नैदानिक संदर्भ में व्याख्या किए जाने चाहिए। केवल लैब रिपोर्ट के आधार पर SLE दवा कभी न बदलें।
Comments
Post a Comment